Community-reported Dantrium side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Dantrium Side Effect Episode
Have You dealt with a Dantrium side effect? Share your experience
Review Dantrium Safety Reports submitted to FDA
Total Dantrium reports: 18.Dantrium FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 5.
Take Dantrium Side Effects Survey, Discuss Dantrium with others
FDA Reported Dantrium Side Effects: rhabdomyolysis, cardio-respiratory arrest, blood creatine phosphokinase increased, gastric ulcer haemorrhage, pyrexia, neuroleptic malignant syndrome, cardiac failure congestive, cardiac failure, arrhythmia, white blood cell count decreased, leukopenia.
Dantrium Usage.
If you have questions about Dantrium, you can ask a Health Expert or Ask Patient Community about Dantrium.
Dantrium Side Effects Report #5213001-0
Physician from UNITED STATES reported DANTRIUM problem on Jan 05, 2007. Male patient, 44 years of age, weighting 300.0 lb, was diagnosed with neuroleptic malignant syndrome, hypertension, schizoaffective disorder and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: agitation, anoxic encephalopathy, apnoea, aspiration, blood creatine phosphokinase increased, brain damage, cardiac arrest, cardio-respiratory arrest. DANTRIUM dosage: 116 MG EVERY 6HR, IV NOS ; 50 MG TWICE DAILY ORAL. During the same period patient was treated with NORVASC, CLOZAPINE, ATENOLOL, CLONAZEPAM, GLIPIZIDE, BROMOCRIPTINE MESYLATE, INSULIN, GLUCOPHAGE. Patient died on 09/01/2006.
Dantrium Side Effects Report #5270096-6
DANTRIUM problem was reported by a Pharmacist from JAPAN on Mar 07, 2007. Male patient, 50 years of age, was diagnosed with spastic paralysis and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: leukopenia, white blood cell count decreased. DANTRIUM dosage: 150 MG/DAY. During the same period patient was treated with LOXONIN, CATLEP, LIORESAL. Patient recovered.
Dantrium Side Effects Report #5275630-8
Pharmacist from JAPAN reported DANTRIUM problem on Mar 14, 2007. Male patient, 50 years of age, was diagnosed with spastic paralysis and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: leukopenia, white blood cell count decreased. DANTRIUM dosage: 150 MG/DAY. During the same period patient was treated with LOXONIN, CATLEP, LIORESAL. Patient recovered.
Dantrium Side Effects Report #5282899-2
DANTRIUM problem was reported by a Pharmacist from JAPAN on Mar 12, 2007. Female patient, child 10 years of age, was diagnosed with hyperthermia malignant and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: arrhythmia, c-reactive protein increased, cardiac failure. DANTRIUM dosage: 40 MG DAILY, IV NOS. During the same period patient was treated with NICARDIPINE HYDROCHLORIDE, DOPAMINE, PRECEDEX, DIPRIVAN. Patient died on 03/11/2007.
Dantrium Side Effects Report #5293794-7
Pharmacist from JAPAN reported DANTRIUM problem on Mar 23, 2007. Female patient, child 10 years of age, was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac failure, myoglobinuria. DANTRIUM dosage: 40 MG DAILY, IV NOS. During the same period patient was treated with DOPAMINE, PRECEDEX, DIPRIVAN, NICARDIPINE HYDROCHLORIDE. Patient died on 03/11/2007.
Dantrium Side Effects Report #5301940-1
DANTRIUM problem was reported by a Pharmacist from UNITED STATES on Apr 16, 2007. Male patient, 80 years of age, weighting 150.0 lb, was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, pleural effusion. DANTRIUM dosage: 25 MG TWICE DAILY PO. Patient was hospitalized. Patient recovered.
Dantrium Side Effects Report #5360783-3
Pharmacist from JAPAN reported DANTRIUM problem on June 06, 2007. Male patient, 28 years of age, was diagnosed with analgesic effect and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, body temperature increased, hyperhidrosis, muscle tightness, neuroleptic malignant syndrome, tonic convulsion, tremor. DANTRIUM dosage: 40 MG. During the same period patient was treated with VEGETAMIN A, GOODMIN, ROHYPNOL, TOLEDOMIN, LEXOTAN, PENTAZOCINE LACTATE, PENTAZOCINE LACTATE. Patient recovered.
Dantrium Side Effects Report #5066151-6
DANTRIUM problem was reported by a Physician from JAPAN on July 10, 2006. Female patient, weighting 17.64 lb, was diagnosed with cerebral palsy and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, pyrexia. DANTRIUM dosage: unknown. Patient was hospitalized. Patient recovered.
Dantrium Side Effects Report #5072945-3
Physician from JAPAN reported DANTRIUM problem on July 18, 2006. Male patient, weighting 17.64 lb, was diagnosed with cerebral palsy and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: antithrombin iii decreased, fluid intake reduced, hepatic function abnormal, hypokalaemia, oral intake reduced, pyrexia, renal impairment, rhabdomyolysis, viith nerve paralysis. DANTRIUM dosage: unknown. During the same period patient was treated with NAUZELIN, TRICLORYL, LAC B, SOLDEM, ESCRE, MUCODYNE, HOKUNALIN, FERROMIA. Patient was hospitalized. Patient recovered.
Dantrium Side Effects Report #5114794-3
DANTRIUM problem was reported by a Pharmacist from JAPAN on Sept 07, 2006. Male patient, 75 years of age, was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: nephrotic syndrome. DANTRIUM dosage: unknown. Patient recovered.
Dantrium Side Effects Report #5122630-4
Physician from FRANCE reported DANTRIUM problem on Sept 20, 2006. Female patient, 16 years of age, was diagnosed with osteosarcoma localised and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, convulsion, cytolytic hepatitis, mucosal inflammation, renal failure, thrombocytopenia, tubulointerstitial nephritis. DANTRIUM dosage: unknown. During the same period patient was treated with METHOTREXATE, ONDANSETRON, METHYLPREDNISOLONE, NALBUPHINE. Patient recovered.
Dantrium Side Effects Report #5134201-4
DANTRIUM problem was reported by a Pharmacist from JAPAN on Oct 04, 2006. Female patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: gastric ulcer haemorrhage, melaena. DANTRIUM dosage: 40 MG DAILY; 2, 1, 2 VIALS FOR A DOSE, IV NOS. During the same period patient was treated with LEVODOPA, AMAZOLON, PERMAX, DOPS. Patient was hospitalized. Patient recovered.
Dantrium Side Effects Report #5136871-3
Physician from JAPAN reported DANTRIUM problem on Oct 11, 2006. Female patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome, parkinson's disease and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: acarodermatitis, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, neuroleptic malignant syndrome, red blood cell count decreased, urinary tract infection. DANTRIUM dosage: 20 MG TWICE DAILY, IV NOS. During the same period patient was treated with MADOPAR, AMAZOLON, DOPS, PERGOLIDE MESYLATE, SOLDEM, DEXTROSE, SOLDOL E. Patient recovered.
Dantrium Side Effects Report #5167503-6
DANTRIUM problem was reported by a Physician from JAPAN on Nov 15, 2006. Male patient, 53 years of age, was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. DANTRIUM dosage: 25 MG DAILY, ORAL. During the same period patient was treated with LIPITOR, CLONAZEPAM, MARZULENE ES, TEGRETOL, ARTANE, TIZANIDINE, ALPRAZOLAM, TICLOPIDINE. Patient recovered.
Dantrium Side Effects Report #5176347-0
Physician from JAPAN reported DANTRIUM problem on Nov 22, 2006. Male patient, 53 years of age, was diagnosed with hyperlipidaemia and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: rhabdomyolysis. DANTRIUM dosage: 25 MG DAILY, ORAL. During the same period patient was treated with LIPITOR, CLONAZEPAM, MARZULENE ES, TEGRETOL, ARTANE, TIZANIDINE, ALPRAZOLAM, TICLOPIDINE. Patient recovered.
Dantrium Side Effects Report #5446083-1
DANTRIUM problem was reported by a Physician from JAPAN on Aug 23, 2007. Male patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. DANTRIUM dosage: 40 MG, 1 ONLY, IV DRIP; 60 MG, 1 ONLY, IV DRIP; 60 MG, 1 ONLY , IV DRIP. Patient died on 08/22/2007.
Dantrium Side Effects Report #5455011-4
Physician from JAPAN reported DANTRIUM problem on Aug 30, 2007. Male patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest. DANTRIUM dosage: 40 MG, 1 ONLY, IV DRIP; 60 MG, 1 ONLY, IV DRIP. During the same period patient was treated with DORAL, GASMOTIN, RIZE, DOXAZOSIN MESYLATE, JUVELA N, METHYCOBAL. Patient died.
Dantrium Side Effects Report #5470661-7
DANTRIUM problem was reported by a Physician from JAPAN on Sept 07, 2007. Male patient, 60 years of age, was diagnosed with neuroleptic malignant syndrome, cardiac failure and was treated with DANTRIUM. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, atrial fibrillation, cardiac failure congestive, cardiomegaly, haemodialysis, hyperventilation, hypoxia, oxygen saturation decreased, rales. DANTRIUM dosage: 25 MG THREE TIMES DAILY, ORAL 50 MG THREE TIMES DAILY, ORAL. During the same period patient was treated with LASIX, LEVOTHYROXINE, GRAMALIL, DEPAS, RISPERDAL. Patient was hospitalized. Patient recovered.
Ask Our Patient Community about Dantrium |
||
|
|
||
|
|
||